Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
出版年份 2012 全文链接
标题
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 134, Issue 3, Pages 1027-1039
出版商
Springer Nature
发表日期
2012-03-28
DOI
10.1007/s10549-012-2032-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
- (2011) E. M. Fox et al. CANCER RESEARCH
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- ER -Dependent E2F Transcription Can Mediate Resistance to Estrogen Deprivation in Human Breast Cancer
- (2011) T. W. Miller et al. Cancer Discovery
- Variation in Anastrozole Metabolism and Pharmacodynamics in Women with Early Breast Cancer
- (2010) J. N. Ingle et al. CANCER RESEARCH
- Targeting Endocrine Resistance: Is There a Role for mTOR Inhibition?
- (2010) Amna Sheri et al. Clinical Breast Cancer
- Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
- (2010) Priscilla F. McAuliffe et al. Clinical Breast Cancer
- High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR Therapy
- (2010) B. C. Litzenburger et al. CLINICAL CANCER RESEARCH
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Enhancing the Efficacy of Hormonal Agents with Selected Targeted Agents
- (2009) Stephen R.D. Johnston Clinical Breast Cancer
- Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial
- (2009) Emanuela Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
- (2008) Matthew J. Sikora et al. BREAST CANCER RESEARCH AND TREATMENT
- Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer
- (2008) J. Michael Dixon et al. JOURNAL OF CLINICAL ONCOLOGY
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- 27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
- (2007) Carolyn D. DuSell et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started